Category list : Anti-obesity agents
Sort by: Newest first Oldest first A-Z Z-A
-
Weight loss drug orlistat may reduce the absorption of HIV medicines
Orlistat, a weight loss drug, may theoretically reduce the absorption of antiretroviral HIV medicines, says the Medicines and Healthcare products Regulatory Agency in its latest Drug Safety Update (March 2014). It recommends that orlistat should only be started after careful consideration of the possible impact and that people on antiretrovirals should consult their doctor before ...
-
Government urged to target anti-obesity campaigns at women
Leading clinicians are urging the Government to fund campaigns demonstrating that obesity problems begin before conception and put both mother and child at risk from serious diseases.
-
Anti-obesity drugs needed unless attitudes change
Unless there is a complete revision of attitudes to obesity, drug therapies should continue to play an important role in treatment, the authors of a Lancet article published online on 27 October argue.
-
Anti-obesity drug does not produce meaningful weight loss
An experimental weight loss drug known as MK-0557 is unlikely to be sufficient as monotherapy to treat obesity, the results from a recently published trial suggest (Cell Metabolism 2006;4:275).
-
PJ Online | News | Anti-obesity drug also helps smokers avoid weight gain
Home PJ (current issue) > News / NewsCentre | Search
-
PJ Online | News: Guidance on anti-obesity drugs
Home PJ (current issue) > News / Daily News | Search
-
PJ Online | News: Report highlights monitoring requirement for anti-obesity drugs
Home PJ (current issue) > News / Daily News | Search
-
PJ Online | News: Novel strategy for anti-obesity drugs
Home PJ (current issue) > News / Daily News | Search
-
PJ Online | News: Anti-obesity drug criticised by the DTB but supported by NICE advice
Home PJ > News / Daily News
- Previous Page
- 1
- 2
- 3
- Next Page
Show 10 per page20 per page50 per page
